Credit Suisse’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $983K | Buy |
57,525
+2,082
| +4% | +$32.7K | ﹤0.01% | 2280 |
|
|
2023
Q4 | $979K | Sell |
55,443
-34,510
| -38% | -$695K | ﹤0.01% | 2344 |
|
|
2023
Q3 | $2.16M | Sell |
89,953
-20,767
| -19% | -$510K | ﹤0.01% | 1793 |
|
|
2023
Q2 | $2.57M | Buy |
110,720
+33,087
| +43% | +$748K | ﹤0.01% | 1751 |
|
|
2023
Q1 | $1.71M | Buy |
77,633
+1,414
| +2% | +$33.1K | ﹤0.01% | 1976 |
|
|
2022
Q4 | $1.54M | Buy |
76,219
+14,852
| +24% | +$288K | ﹤0.01% | 2037 |
|
|
2022
Q3 | $828K | Sell |
61,367
-2,351
| -4% | -$39.6K | ﹤0.01% | 2456 |
|
|
2022
Q2 | $1.26M | Buy |
63,718
+20,721
| +48% | +$550K | ﹤0.01% | 2229 |
|
|
2022
Q1 | $1.36M | Buy |
42,997
+4,731
| +12% | +$133K | ﹤0.01% | 2334 |
|
|
2021
Q4 | $853K | Sell |
38,266
-4,232
| -10% | -$110K | ﹤0.01% | 3439 |
|
|
2021
Q3 | $1.18M | Sell |
42,498
-9,878
| -19% | -$301K | ﹤0.01% | 3205 |
|
|
2021
Q2 | $2.04M | Sell |
52,376
-4,145
| -7% | -$149K | ﹤0.01% | 2847 |
|
|
2021
Q1 | $1.63M | Buy |
56,521
+11,919
| +27% | +$407K | ﹤0.01% | 2972 |
|
|
2020
Q4 | $1.18M | Buy |
44,602
+3,624
| +9% | +$74K | ﹤0.01% | 3220 |
|
|
2020
Q3 | $625K | Buy |
40,978
+7,436
| +22% | +$156K | ﹤0.01% | 3256 |
|
|
2020
Q2 | $682K | Sell |
33,542
-5,293
| -14% | -$94.9K | ﹤0.01% | 3135 |
|
|
2020
Q1 | $401K | Sell |
38,835
-14,052
| -27% | -$393K | ﹤0.01% | 3245 |
|
|
2019
Q4 | $1.99M | Buy |
52,887
+1,160
| +2% | +$52.1K | ﹤0.01% | 2601 |
|
|
2019
Q3 | $2.41M | Buy |
51,727
+1,648
| +3% | +$76.6K | ﹤0.01% | 2328 |
|
|
2019
Q2 | $2.62M | Sell |
50,079
-3,122
| -6% | -$183K | ﹤0.01% | 2253 |
|
|
2019
Q1 | $3.67M | Sell |
53,201
-11,965
| -18% | -$802K | ﹤0.01% | 1954 |
|
|
2018
Q4 | $3.89M | Buy |
65,166
+4,321
| +7% | +$373K | ﹤0.01% | 1764 |
|
|
2018
Q3 | $7.05M | Sell |
60,845
-3,058
| -5% | -$345K | 0.01% | 1477 |
|
|
2018
Q2 | $8.06M | Buy |
63,903
+2,311
| +4% | +$281K | 0.01% | 1368 |
|
|
2018
Q1 | $6.67M | Sell |
61,592
-14,651
| -19% | -$1.62M | 0.01% | 1515 |
|
|
2017
Q4 | $8.35M | Buy |
76,243
+9,919
| +15% | +$990K | 0.01% | 1408 |
|
|
2017
Q3 | $6.55M | Buy |
66,324
+7,910
| +14% | +$767K | 0.01% | 1553 |
|
|
2017
Q2 | $5.92M | Sell |
58,414
-11,210
| -16% | -$1.21M | 0.01% | 1527 |
|
|
2017
Q1 | $8.04M | Buy |
69,624
+11,678
| +20% | +$1.36M | 0.01% | 1334 |
|
|
2016
Q4 | $6.96M | Buy |
57,946
+4,623
| +9% | +$512K | 0.01% | 1433 |
|
|
2016
Q3 | $5.99M | Sell |
53,323
-1,116
| -2% | -$129K | 0.01% | 1523 |
|
|
2016
Q2 | $6.75M | Sell |
54,439
-9,264
| -15% | -$1.12M | 0.01% | 1432 |
|
|
2016
Q1 | $7.16M | Sell |
63,703
-5,350
| -8% | -$556K | 0.01% | 1304 |
|
|
2015
Q4 | $7.51M | Buy |
69,053
+8,584
| +14% | +$983K | 0.01% | 1314 |
|
|
2015
Q3 | $6.04M | Sell |
60,469
-5,368
| -8% | -$584K | 0.01% | 1422 |
|
|
2015
Q2 | $7.51M | Buy |
65,837
+1,226
| +2% | +$149K | 0.01% | 1441 |
|
|
2015
Q1 | $6.75M | Sell |
64,611
-15,095
| -19% | -$1.61M | 0.01% | 1443 |
|
|
2014
Q4 | $9.59M | Buy |
79,706
+13,971
| +21% | +$1.84M | 0.01% | 1316 |
|
|
2014
Q3 | $9.62M | Buy |
65,735
+4,999
| +8% | +$772K | 0.01% | 1311 |
|
|
2014
Q2 | $10.1M | Sell |
60,736
-21,921
| -27% | -$3.9M | 0.01% | 1389 |
|
|
2014
Q1 | $16.4M | Buy |
82,657
+3,146
| +4% | +$594K | 0.02% | 935 |
|
|
2013
Q4 | $15.2M | Buy |
79,511
+27,863
| +54% | +$5.19M | 0.01% | 991 |
|
|
2013
Q3 | $8.74M | Sell |
51,648
-18,118
| -26% | -$2.81M | 0.01% | 1221 |
|
|
2013
Q2 | $10.6M | Buy |
+69,766
| New | +$9.89M | 0.01% | 1101 |
|
Other funds holding CLB
AI
CAM
RA
FAM
Credit Suisse's CLB Position: Q1 2024 in Review
Credit Suisse increased its Core Laboratories (CLB) stake by 3.8% in Q1 2024, buying an estimated $32.7K and bringing the position to 57,525 shares worth $983K. The position accounts for ﹤0.01% of the portfolio, ranked #2280.
Credit Suisse first reported a position in CLB in Q2 2013 and has held it in 44 quarters since. The position peaked at $16.4M in Q1 2014. 197 funds tracked by Wall St. Rank hold CLB as of Q1 2024.
- Credit Suisse held 57,525 shares of Core Laboratories worth $983K as of Q1 2024.
- Credit Suisse bought 2,082 Core Laboratories shares in Q1 2024, an estimated $32.7K.
- Core Laboratories made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2280 holding.
- Credit Suisse first reported a position in Core Laboratories in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Core Laboratories position peaked at $16.4M in Q1 2014.
- 197 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.